PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Molecular Virology, Ulm University Medical Center, 89081, Ulm, Germany.\', \'Institute for Epidemiology and Medical Biometry, Ulm University, Ulm, Germany.\', \'Infection Biology Unit, German Primate Center - Leibniz Institute for Primate Research, Göttingen, Germany; Faculty of Biology and Psychology, Georg-August-University Göttingen, Göttingen, Germany.\', \'Department of Microbiology and Department of Medicine, University of Pennsylvania, Philadelphia, USA.\', \'Central Department for Clinical Chemistry, University Hospital Ulm, 89081, Ulm, Germany.\', \'Institute for Transfusion Medicine, Ulm University, 89081, Ulm, Germany; Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Services Baden-Württemberg-Hessen and University Hospital Ulm, 89081, Ulm, Germany.\', \'Institute of Molecular Virology, Ulm University Medical Center, 89081, Ulm, Germany; Core Facility Functional Peptidomics, Ulm University Medical Center, 89081, Ulm, Germany.\', \'Institute of Molecular Virology, Ulm University Medical Center, 89081, Ulm, Germany. Electronic address: Janis.mueller@uni-ulm.de.\']
?:citedBy
  • -1
?:creator
?:doi
  • S2352-3964(21)00555-710.1016/j.ebiom.2021.103761
?:doi
?:hasPublicationType
?:journal
  • EBioMedicine
is ?:pmid of
?:pmid
?:pmid
  • 34929493
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.895
?:rankingScore_hIndex
  • 26
is ?:relation_isRelatedTo_publication of
?:title
  • Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all